Determinants of plasma calretinin in patients with malignant pleural mesothelioma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-0500
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Determinants of plasma calretinin in patients with malignant pleural mesothelioma ; volume:13 ; number:1 ; day:29 ; month:7 ; year:2020 ; pages:1-6 ; date:12.2020
BMC Research Notes / Biomed Central; 13, Heft 1 (29.7.2020), 1-6, 12.2020
- Urheber
-
Lehnert, Martin
Weber, Daniel G.
Taeger, Dirk
Raiko, Irina
Kollmeier, Jens
Stephan-Falkenau, Susann
Brüning, Thomas
Johnen, Georg
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13104-020-05187-y
- URN
-
urn:nbn:de:101:1-2020092522034582904266
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lehnert, Martin
- Weber, Daniel G.
- Taeger, Dirk
- Raiko, Irina
- Kollmeier, Jens
- Stephan-Falkenau, Susann
- Brüning, Thomas
- Johnen, Georg
- SpringerLink (Online service)
Ähnliche Objekte (12)
Determinants of plasma calretinin in patients with malignant pleural mesothelioma
Untersuchungen zur Charakterisierung von LDL- und HDL-Rezeptoren
Identification of miRNA-103 in the cellular fraction of human peripheral blood as a potential biomarker for malignant mesothelioma : a pilot study
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
Molecular biological analysis of malignant pleural mesothelioma
Assessment of miR-103a-3p in leukocytes : no diagnostic benefit in combination with the blood-based biomarkers mesothelin and calretinin for malignant pleural mesothelioma diagnosis
Lung cancer and mesothelioma risks in a prospective cohort of workers with asbestos-related lung or pleural diseases
Combination of MiR-103a-3p and mesothelin improves the biomarker performance of malignant mesothelioma diagnosis
Circulating miR-132-3p as a candidate diagnostic biomarker for malignant mesothelioma
Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma
Determinants of plasma calretinin in patients with malignant pleural mesothelioma
Untersuchungen zur Charakterisierung von LDL- und HDL-Rezeptoren
Identification of miRNA-103 in the cellular fraction of human peripheral blood as a potential biomarker for malignant mesothelioma : a pilot study
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
Molecular biological analysis of malignant pleural mesothelioma
Assessment of miR-103a-3p in leukocytes : no diagnostic benefit in combination with the blood-based biomarkers mesothelin and calretinin for malignant pleural mesothelioma diagnosis
Lung cancer and mesothelioma risks in a prospective cohort of workers with asbestos-related lung or pleural diseases
Combination of MiR-103a-3p and mesothelin improves the biomarker performance of malignant mesothelioma diagnosis
Circulating miR-132-3p as a candidate diagnostic biomarker for malignant mesothelioma
Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma
Determinants of plasma calretinin in patients with malignant pleural mesothelioma
Untersuchungen zur Charakterisierung von LDL- und HDL-Rezeptoren
Identification of miRNA-103 in the cellular fraction of human peripheral blood as a potential biomarker for malignant mesothelioma : a pilot study
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
Molecular biological analysis of malignant pleural mesothelioma
Assessment of miR-103a-3p in leukocytes : no diagnostic benefit in combination with the blood-based biomarkers mesothelin and calretinin for malignant pleural mesothelioma diagnosis
Lung cancer and mesothelioma risks in a prospective cohort of workers with asbestos-related lung or pleural diseases
Combination of MiR-103a-3p and mesothelin improves the biomarker performance of malignant mesothelioma diagnosis
Circulating miR-132-3p as a candidate diagnostic biomarker for malignant mesothelioma